P Ballardini, I Cicognani, E Montanari, F Fabbri, R Ferrari, A Del Noce
{"title":"慢性丙型病毒性肝炎患者干扰素治疗后出现抗dna抗体。","authors":"P Ballardini, I Cicognani, E Montanari, F Fabbri, R Ferrari, A Del Noce","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. We report the case of a 55-years-old woman who developed anti-DNA and anti-nuclear antibodies after a 9 months treatment with alpha-IFN for chronic hepatitis C. Autoantibodies appearance has not modified the response to therapy; no clinical sign of autoimmune disease is appeared in a 5 months follow-up. HLA typing didn't show a genetic predisposition for the development of autoimmune reactions.</p>","PeriodicalId":21382,"journal":{"name":"Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques","volume":"17 4","pages":"131-2"},"PeriodicalIF":0.0000,"publicationDate":"1995-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Appearance of anti-DNA antibodies after treatment with interferon in a patient with chronic type C viral hepatitis].\",\"authors\":\"P Ballardini, I Cicognani, E Montanari, F Fabbri, R Ferrari, A Del Noce\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. We report the case of a 55-years-old woman who developed anti-DNA and anti-nuclear antibodies after a 9 months treatment with alpha-IFN for chronic hepatitis C. Autoantibodies appearance has not modified the response to therapy; no clinical sign of autoimmune disease is appeared in a 5 months follow-up. HLA typing didn't show a genetic predisposition for the development of autoimmune reactions.</p>\",\"PeriodicalId\":21382,\"journal\":{\"name\":\"Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques\",\"volume\":\"17 4\",\"pages\":\"131-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Appearance of anti-DNA antibodies after treatment with interferon in a patient with chronic type C viral hepatitis].
The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. We report the case of a 55-years-old woman who developed anti-DNA and anti-nuclear antibodies after a 9 months treatment with alpha-IFN for chronic hepatitis C. Autoantibodies appearance has not modified the response to therapy; no clinical sign of autoimmune disease is appeared in a 5 months follow-up. HLA typing didn't show a genetic predisposition for the development of autoimmune reactions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
